Improving health for Black COVID-19 survivors and their caregivers
Improving the Collaborative Health of Minority COVID-19 Survivor and Carepartner Dyads Through Interventions Targeting Social and Structural Health Inequities.
This study is testing a telehealth program to help Black COVID-19 survivors and their caregivers improve their health and manage chronic conditions better.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 500 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of South Carolina Academic / other |
| Locations | 1 site (Columbia, South Carolina) |
| Trial ID | NCT05370014 on ClinicalTrials.gov |
What this trial studies
This study tests a dyadic intervention aimed at improving health outcomes for African American adults who have survived COVID-19 and their informal caregivers. It focuses on individuals with pre-existing chronic health conditions, such as diabetes and cardiovascular diseases, particularly in socioeconomically disadvantaged and rural areas. The intervention, known as iCINGS FAM, is a telehealth program delivered by a team of registered nurses and community health workers over 14 weeks, addressing both health management and social determinants of health. The goal is to enhance chronic disease self-management and overall quality of life for participants.
Who should consider this trial
Good fit: Ideal candidates include African American adults aged 18 and older who have survived COVID-19 and have a history of chronic health conditions, along with their informal caregivers.
Not a fit: Patients who are not African American, do not have a history of COVID-19 hospitalization, or are not living in a medically underserved or rural area may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly improve health outcomes and quality of life for African American COVID-19 survivors and their caregivers.
How similar studies have performed: Other studies have shown success with similar community-based interventions targeting health disparities, particularly among minority populations.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: COVID-19 survivor inclusion criteria * African American * Male and female * Living in a Medically Underserved Area and/or a designated rural area of South Carolina * ≥ 18 years and above * A history of a COVID-19-associated hospitalization, ER or Urgent Care visit since March 11th, 2020 * A previous diagnosis of one or more of the following conditions: type 2 diabetes, hypertension, cardiovascular disease, chronic kidney disease, or stroke (\>3 months) -Carepartner inclusion criteria * Male and female * ≥ 18 years and above * Must live on the same property or community, preferably within a 40-mile radius of the survivor * Primarily responsible for care provision and/or care/social support in the home (i.e., is not paid for services) Exclusion Criteria: * Survivor and Carepartner exclusion criteria • Enrolled in related clinical trials
Where this trial is running
Columbia, South Carolina
- University of South Carolina — Columbia, South Carolina, United States (Recruiting)
Study contacts
- Principal investigator: Gayenell S Magwood, PhD — University of South Carolina
- Study coordinator: Study PI
- Email: magwoodg@sc.edu
- Phone: 8037779160
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.